Michigan Capital Network Ventures
Michigan Capital Network Ventures, located in Grand Rapids, Michigan, is a prominent venture capital firm that actively invests in seed-stage, early-stage, and later-stage companies. The firm focuses on a diverse range of sectors, including business products, business services, information technology, healthcare, life sciences, manufacturing, software as a service (SaaS), artificial intelligence, and machine learning. Michigan Capital Network Ventures aims to foster the growth of strong entrepreneurs and businesses in Michigan and the Midwest by not only providing financial support but also offering mentorship and access to extensive networking opportunities. The firm is dedicated to the success of its portfolio companies, recognizing that their achievements contribute to the broader economic development of the region.
ATLAS Space Operations
Venture Round in 2024
ATLAS Space Operations, Inc. specializes in revolutionizing satellite communications through its innovative software platform. Founded in 2015 and headquartered in Traverse City, Michigan, the company offers the ATLAS Freedom Software Platform, a cloud-based space management and control system. This platform enables users to gather and process data from space efficiently, featuring capabilities such as flexible scheduling, cloud processing, and integration with AWS services. ATLAS also operates a global network of antennas to provide affordable and scalable ground communication solutions. With a focus on improving the accessibility and affordability of space-based communications, ATLAS aims to transform the industry and enhance how data from satellites is utilized on Earth.
ADHD Online
Series A in 2023
ADHD Online provides a formal evaluation for mental health conditions from its licensed psychologist's nationwide network. ADHD Online also provides treatment including medication management, virtual therapy, and other resources. The company was founded in 2018 and is headquartered in Grand Rapids, Michigan.
ONL Therapeutics
Series C in 2023
ONL Therapeutics is a biopharmaceutical company focused on developing innovative therapeutics to protect and improve vision in patients with retinal diseases and conditions. Founded in 2006 and headquartered in Ann Arbor, Michigan, the company specializes in creating photoreceptor protective agents that target the FAS apoptotic pathway. Its drug programs aim to safeguard photoreceptors, thereby enhancing outcomes for patients undergoing surgeries related to retinal detachment and other serious vision-threatening issues. Through its research and development efforts, ONL Therapeutics seeks to provide effective solutions for preserving sight and improving the quality of life for individuals affected by these conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.